Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Internal Medicine · JACKSONVILLE, FL · NPI 1316479744
Verified facts
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
We did not find matching Open Payments records for this doctor in the selected program year.
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 544 | 279 |
| Amlodipine Besylate | Amlodipine Besylate | 338 | 193 |
| Lisinopril | Lisinopril | 265 | 132 |
| Losartan Potassium | Losartan Potassium | 259 | 144 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 208 | 109 |
| Levothyroxine Sodium | Levothyroxine Sodium | 198 | 95 |
| Gabapentin | Gabapentin | 173 | 85 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 166 | 93 |
| Metformin Hcl | Metformin Hcl | 163 | 88 |
| Hydrochlorothiazide | Hydrochlorothiazide | 158 | 82 |
| Omeprazole | Omeprazole | 150 | 87 |
| Pantoprazole Sodium | Pantoprazole Sodium | 150 | 72 |
| Fluticasone Propionate | Fluticasone Propionate | 114 | 60 |
| Furosemide | Furosemide | 110 | 65 |
| Metoprolol Succinate | Metoprolol Succinate | 97 | 51 |
| Carvedilol | Carvedilol | 95 | 48 |
| Trazodone Hcl | Trazodone Hcl | 90 | 38 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 80 | 37 |
| Alendronate Sodium | Alendronate Sodium | 76 | 51 |
| Meloxicam | Meloxicam | 74 | 49 |
| Mounjaro | Tirzepatide | 74 | 23 |
| Metoprolol Tartrate | Metoprolol Tartrate | 70 | 37 |
| Ozempic | Semaglutide | 69 | 21 |
| Potassium Chloride | Potassium Chloride | 69 | 32 |
| Ezetimibe | Ezetimibe | 64 | 36 |
| Famotidine | Famotidine | 64 | 35 |
| Montelukast Sodium | Montelukast Sodium | 61 | 36 |
| Ibuprofen | Ibuprofen | 60 | 34 |
| Diclofenac Sodium | Diclofenac Sodium | 59 | 42 |
| Hydralazine Hcl | Hydralazine Hcl | 59 | 32 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 59 | 22 |
| Tramadol Hcl | Tramadol Hcl | 57 | 29 |
| Clopidogrel | Clopidogrel Bisulfate | 56 | 33 |
| Tamsulosin Hcl | Tamsulosin Hcl | 56 | 31 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 54 | 32 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 53 | 30 |
| Alprazolam | Alprazolam | 52 | 16 |
| Bupropion Hcl Sr | Bupropion Hcl | 51 | 18 |
| Pravastatin Sodium | Pravastatin Sodium | 50 | 30 |
| Allopurinol | Allopurinol | 49 | 33 |
| Jardiance | Empagliflozin | 49 | 18 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 49 | 16 |
| Zolpidem Tartrate | Zolpidem Tartrate | 49 | 13 |
| Buspirone Hcl | Buspirone Hcl | 47 | 22 |
| Escitalopram Oxalate | Escitalopram Oxalate | 46 | 21 |
| Glimepiride | Glimepiride | 46 | 22 |
| Ondansetron Odt | Ondansetron | 46 | 23 |
| Metformin Hcl Er | Metformin Hcl | 44 | 29 |
| Simvastatin | Simvastatin | 44 | 31 |
| Atenolol | Atenolol | 43 | 22 |
| Azithromycin | Azithromycin | 40 | 39 |
| Fluconazole | Fluconazole | 40 | 26 |
| Methylprednisolone | Methylprednisolone | 40 | 37 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 40 | 29 |
| Citalopram Hbr | Citalopram Hydrobromide | 39 | 19 |
| Tizanidine Hcl | Tizanidine Hcl | 39 | 17 |
| Duloxetine Hcl | Duloxetine Hcl | 38 | 25 |
| Eliquis | Apixaban | 36 | 16 |
| Pioglitazone Hcl | Pioglitazone Hcl | 36 | 21 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 35 | 21 |
| Baclofen | Baclofen | 34 | 18 |
| Sertraline Hcl | Sertraline Hcl | 34 | 20 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 33 | 32 |
| Donepezil Hcl | Donepezil Hcl | 32 | 20 |
| Valsartan | Valsartan | 29 | 13 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 28 | 16 |
| Sumatriptan Succinate | Sumatriptan Succinate | 28 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 26 | suppressed |
| Naproxen | Naproxen | 26 | 22 |
| Glipizide Er | Glipizide | 25 | 13 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 25 | 15 |
| Clonidine Hcl | Clonidine Hcl | 24 | 17 |
| Spironolactone | Spironolactone | 24 | 12 |
| Estradiol | Estradiol | 23 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 23 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 23 | 13 |
| Januvia | Sitagliptin Phosphate | 23 | 15 |
| Novolog Flexpen | Insulin Aspart | 23 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 23 | 18 |
| Solifenacin Succinate | Solifenacin Succinate | 23 | 14 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 23 | 12 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 22 | 18 |
| Mirtazapine | Mirtazapine | 22 | 11 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 22 | suppressed |
| Nifedipine Er | Nifedipine | 22 | suppressed |
| Trulicity | Dulaglutide | 22 | suppressed |
| Clonazepam | Clonazepam | 21 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Methocarbamol | Methocarbamol | 21 | suppressed |
| Sucralfate | Sucralfate | 21 | suppressed |
| Xarelto | Rivaroxaban | 21 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 20 | 12 |
| Chlorthalidone | Chlorthalidone | 19 | suppressed |
| Finasteride | Finasteride | 19 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 19 | suppressed |
| Celecoxib | Celecoxib | 18 | suppressed |
| Ciclopirox | Ciclopirox | 18 | suppressed |
| Glipizide | Glipizide | 18 | 11 |
| Lidocaine | Lidocaine | 18 | suppressed |
| Mupirocin | Mupirocin | 18 | 16 |
| Prednisone | Prednisone | 18 | 12 |
| Azelastine Hcl | Azelastine Hcl | 17 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 17 | 11 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 17 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 16 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 16 | 15 |
| Ropinirole Hcl | Ropinirole Hcl | 16 | suppressed |
| Topiramate | Topiramate | 16 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 16 | suppressed |
| Aripiprazole | Aripiprazole | 15 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 15 | suppressed |
| Levemir Flexpen | Insulin Detemir | 15 | suppressed |
| Linzess | Linaclotide | 15 | suppressed |
| Rybelsus | Semaglutide | 15 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 15 | suppressed |
| Kerendia | Finerenone | 14 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 14 | 14 |
| Restasis | Cyclosporine | 14 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 14 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 13 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 13 | suppressed |
| Nystatin | Nystatin | 13 | 11 |
| Breo Ellipta | Fluticasone/Vilanterol | 12 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 12 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 12 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 12 | suppressed |
| Levetiracetam | Levetiracetam | 12 | suppressed |
| Pregabalin | Pregabalin | 12 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 12 | suppressed |
| Cefdinir | Cefdinir | 11 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 11 | suppressed |
| Eszopiclone | Eszopiclone | 11 | suppressed |
| Lorazepam | Lorazepam | 11 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 11 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 11 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 11 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 11 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error